| ProductNum | picture | CAS No. | Name and description | Size | Price | Formula | Quick order |
|---|---|---|---|---|---|---|---|
| TOF-001001 |
|
540737-29-9 |
Tofacitinib Citrate - - 95%+ |
0 | Inquiry | C16H20N6O∙C6H8O7 | |
| EMP-001002 |
|
864070-44-0 (non-labelled) |
Empagliflozin-d4 - - 95%+ |
0 | Inquiry | C23H23D4ClO7 | |
| EMP-001001 |
|
864070-44-0 |
Empagliflozin - - 95%+ |
0 | Inquiry | C23H27ClO7 | |
| MET-001002 |
|
1185166-01-1 |
N,N-dimethyl-d6 imidodicarbonimidic diamide, hydrochloride (1:1) - - 95%+ |
0 | Inquiry | C4H6ClD6N5 | |
| MET-001001 |
|
1115-70-4 |
N/A - - 95%+ |
0 | Inquiry | C4H12ClN5 | |
| DAC-001002 |
|
1110813-31-4 (non-labelled) |
(E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl-d10)but-2-enamide - - 95%+ |
0 | Inquiry | C24H15D10ClFN5O2 | |
| DAC-001001 |
|
1110813-31-4 |
(E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide - - 95%+ |
0 | Inquiry | C24H25ClFN5O2 | |
| PEM-001001 |
|
848259-27-8 |
(R)-2-(3-((benzo[d]oxazol-2-yl(3-(4-methoxyphenoxy)propyl)amino)methyl)phenoxy)butanoic acid - - 95%+ |
0 | Inquiry | C28H30N2O6 | |
| APR-001002 |
|
1133387-60-6 |
5-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl-2,3,5,6-d4)morpholino)methyl)-1,2-dihydro-3H-1,2,4-triazol-3-one - - 95%+ |
0 | Inquiry | C23H17D4F7N4O3 | |
| APR-001001 |
|
170729-80-3 |
3-(((2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-1H-1,2,4-triazol-5(4H)-one - - 95%+ |
0 | Inquiry | C23H21F7N4O3 | |
| APA-001001 |
|
956104-40-8 (non-labelled) |
4-(7-(6-cyano-5-(trifluoromethyl)pyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]octan-5-yl)-2-fluoro-N-(methyl-13C-d3)benzamide - - 95%+ |
0 | Inquiry | C2013CH12D3F4N5O2S | |
| ENZ-001001 |
|
1443331-94-9 |
4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-methylbenzamide - - 95%+ |
0 | Inquiry | C21H16F4N4O2S | |
| DIG-001014 |
|
20830-75-5(non-labelled) |
4-((3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-(((2R,4S,5S,6R)-5-(((2S,4S,5S,6R)-5-(((2S,4S,5S,6R)-4,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-12,14-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one-3,5,5-d3 - - 95%+ |
0 | Inquiry | C41H61D3O14 | |
| DYP-001003 |
|
603-00-9 |
7-(2-hydroxypropyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione - - 95%+ |
0 | Inquiry | C10H14N4O3 | |
| DYP-001002 |
|
519-37-9 |
7-(2-hydroxyethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione - - 95%+ |
0 | Inquiry | C9H12N4O3 | |
| DYP-001001 |
|
6736-40-9 |
N-Methyl-5-methylamino-1H-imidazole-4-carboxamide - - 95%+ |
0 | Inquiry | 6736-40-9 | |
| DIG-001013 |
|
— |
N/A - - 95%+ |
0 | Inquiry | C41 H66 O14 | |
| DIG-001012 |
|
31539-05-6 |
N/A - - 95%+ |
0 | Inquiry | C47H74O17 | |
| DIG-001011 |
|
5355-48-6 |
2R,3S,4S,6S)-6-(((2R,3S,4S,6S)-6-(((2R,3S,4S,6R)-6-(((3S,5R,8R,9S,10S,12R,13S,14S,17R)-12,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2,5-dihydrofuran-3-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-4-hydroxy-2-methyltetrahydro-2H-pyran-3-yl)oxy)-4-hydroxy-2-methyltetrahydro-2H-pyran-3-yl)oxy)-4-hydroxy-2-methyltetrahydro-2H-pyran-3-yl acetate - - 95%+ |
0 | Inquiry | C43H66O15 | |
| DIG-001010 |
|
5511-98-8 |
(2R,3R,4S,6S)-6-(((2R,3S,4S,6S)-6-(((2R,3S,4S,6R)-6-(((3S,5R,8R,9S,10S,12R,13S,14S,17R)-12,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2,5-dihydrofuran-3-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-4-hydroxy-2-methyltetrahydro-2H-pyran-3-yl)oxy)-4-hydroxy-2-methyltetrahydro-2H-pyran-3-yl)oxy)-3-hydroxy-2-methyltetrahydro-2H-pyran-4-yl acetate - - 95%+ |
0 | Inquiry | C43H66O15 | |
Hotline
|
022-1561561656
|
|
After sale
|
022-1561561656
|